Results 61 to 70 of about 6,321,039 (371)
A Generative Approach for Image Registration of Visible-Thermal (VT) Cancer Faces [PDF]
2nd Annual Artificial Intelligence over Infrared Images for
Medical Applications Workshop 2023, 2023 Since thermal imagery offers a unique modality to investigate pain, the U.S. National Institutes of Health (NIH) has collected a large and diverse set of cancer patient facial thermograms for AI-based pain research. However, differing angles from camera capture between thermal and visible sensors has led to misalignment between Visible-Thermal (VT ...
arxiv
Palliative Medicine, 2018 Background: Combining antidepressant or antiepileptic drugs with opioids has resulted in increased pain relief when used for neuropathic pain in non-cancer conditions. However, evidence to support their effectiveness in cancer pain is lacking.
C. Kane +5 more
semanticscholar +1 more source
Journal of Pain and Symptom Management, 1987 Recognizing and treating the cause of pain in the patient with cancer should be the initial approach to the management of this common symptom. Careful analysis of patients with cancer and pain has led to the elucidation of common pain syndromes unique to this disease process (Table 1).
openaire +2 more sources
Egyptian Journal of Anaesthesia, 2017 Background: Previous studies have shown that dexmedetomidine has proven effectiveness as sedative in many outpatient settings and several reports are now available documenting its success for sedation of both non-invasive and invasive procedures ...
Ayat Abdelfattah Hassan +5 more
doaj +1 more source
Breast Cancer Induced Bone Osteolysis Prediction Using Temporal Variational Auto-Encoders [PDF]
arXiv, 2022 Objective and Impact Statement. We adopt a deep learning model for bone osteolysis prediction on computed tomography (CT) images of murine breast cancer bone metastases. Given the bone CT scans at previous time steps, the model incorporates the bone-cancer interactions learned from the sequential images and generates future CT images.
arxiv
Ketamine as an adjuvant to opioids for cancer pain.
Cochrane Database of Systematic Reviews, 2017 BACKGROUND Ketamine is a commonly used anaesthetic agent, and in subanaesthetic doses is also given as an adjuvant to opioids for the treatment of cancer pain, particularly when opioids alone prove to be ineffective.
R. Bell, C. Eccleston, E. Kalso
semanticscholar +1 more source
Molecular Oncology, EarlyView.Patient engagement involves actively including patients in healthcare decisions and research to ensure care and studies align with their needs. This approach improves outcomes, trust, and communication while fostering collaboration between patients and professionals.
Estela Cepeda +3 more
wiley +1 more source
Pain and TherapyIntroduction Methadone has shown effectiveness in pain control in patients with cancer who are intolerant to other opioids in China. However, the optimal strategy for methadone conversion from previous high doses of opioids in refractory cancer pain ...
Lei Lei +6 more
doaj +1 more source
BMC Medicine, 2022 Background Oral mucositis (OM) in patients receiving cancer therapy is thus far not well managed with standard approaches. We aimed to assess the safety and effectiveness of methylene blue (MB) oral rinse for OM pain in patients receiving cancer therapy.
Carlos J. Roldan +8 more
doaj +1 more source
Antioxidants, 2022 Hesperidin is derived from citrus fruits among other plants. Hesperidin was methylated to increase its solubility, generating hesperidin methyl chalcone (HMC), an emerging flavonoid that possess anti-inflammatory and antioxidant properties.
Allan J. C. Bussmann +12 more
doaj +1 more source